Search clinical trials for: Fosrenol (Lanthanum Carbonate, BAY77-1931)

Total 49 results

Bayer

Completed

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Clinical Pharmacology

Japan
Bayer

Completed

Bioequivalence Study of BAY77-1931 Granule

Hyperphosphatemia

Japan
Bayer

Completed

Fosrenol Post-marketing Surveillance in Japan

Hyperphosphatemia | Kidney Disease

Japan
Bayer
Shire

Completed

Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

Hyperphosphatemia

Japan
Bayer
Shire

Completed

Study in Chronic Kidney Disease (CKD) Not on Dialysis

Hyperphosphatemia

Japan
Bayer

Completed

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Hyperphosphatemia

Japan
Bayer

Completed

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan (FOSRENOL-HD)

Hyperphosphatemia

Japan
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Bayer

Completed

Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients

Hyperphosphatemia

Japan
Shire

Completed

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

End Stage Renal Disease

United States
Lundquist Institute for Biomedical Innovation at...

Completed

Fosrenol and Phosphorus Balance - Lanthanum Carbonate

End-stage Renal Disease | Chronic Kidney Failure | Disorders Associated With Peritoneal Dialysis

United States
Shire

Terminated

Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5

Kidney Diseases

Netherlands, Germany, Austria, Belgium, Denmark, Italy
University of Illinois at Chicago
Shire

Completed

Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients

Hyperphosphatemia | Kidney Disease

United States
Shire

Completed

Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease

Kidney Diseases

United States
Shire

Completed

Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD

Chronic Kidney Disease

France
Astellas Pharma Inc
FibroGen

Completed

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

Healthy Subjects

Japan
NorthShore University HealthSystem
Shire

Completed

The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease

Metabolic Bone Disease

United States
Geoffrey Block

Completed

Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease

Chronic Kidney Disease

United States
Shire

Completed

Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy

End Stage Renal Disease

Germany
Shire

Completed

Head to Head Study Against Sevelamer Hydrochloride

Chronic Kidney Disease, Stage 5

United States, Germany, Puerto Rico, United Kingdom
Bayer

Completed

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

Hyperphosphatemia

Japan
Myles Wolf
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

Kidney Disease

United States
Shire

Completed

Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers

Kidney Failure, Chronic

United States
University of Wisconsin, Madison
Shire

Completed

Efficacy of Lanthanum Carbonate in Calciphylaxis

Calciphylaxis

United States
Shire

Completed

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Kidney Failure, Chronic
Shire

Completed

Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis

Kidney Failure, Chronic
Shire

Completed

Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

Kidney Failure, Chronic
Shire

Completed

Long-term Effect of Lanthanum Carbonate on Bone

Hyperphosphatemia

United States, Germany, United Kingdom
Universitair Ziekenhuis Brussel

Recruiting

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis (LaCa)

Nephrolithiasis | Secondary Hyperoxaluria

Belgium
Shire

Completed

A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.

Kidney Failure, Chronic
Ineos Healthcare Limited

Terminated

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate

Chronic Kidney Failure

United States, Canada, Australia, New Zealand, Brazil, France, Germany, Malta, Poland, South Africa, Spain
Northwestern University

Completed

Healthy Combine Study

Healthy

United States
University of Illinois at Chicago
Shire

Completed

Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate

Hyperphosphatemia in Chronic Kidney Disease

United States
Osaka University
Bayer

Enrolling by invitation

Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia (LAVALIER)

Renal Insufficiency, Chronic | Bone Diseases, Metabolic | Hyperphosphatemia

Japan
Shire

Completed

Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease

Kidney Failure, Chronic
Medical University of Lodz
Shire

Completed

Different Effects of Non-calcium Phosphate Binders on Serum Calcium

Chronic Kidney Disease

Poland
Camillians Saint Mary's Hospital Luodong

Unknown

The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23

Other Nonspecific Abnormal Serum Enzyme Levels

Taiwan
Massachusetts General Hospital
Shire

Completed

Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease

Chronic Kidney Disease

United States
Lundquist Institute for Biomedical Innovation at...
Shire; DaVita Dialysis

Completed

Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study (FrEDI)

End-Stage Renal Disease
Denver Nephrologists, P.C.
Novartis Pharmaceuticals; Genzyme, a Sanofi Company; Shire; Fresenius Medical Care... and other collaborators

Completed

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

Chronic Kidney Disease

United States
Shire

Completed

The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers

Healthy

United States
Grand Life Science (Liaoning) Co., Ltd.
The First Hospital of Jilin University

Recruiting

To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder

Hyperphosphatemia

China
VA Office of Research and Development

Completed

Phosphate Lowering in CKD Trial

Cardiovascular Disease | Chronic Kidney Disease

United States
The Cleveland Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE (COMBINE)

Chronic Kidney Disease

United States
Translational Research Center for Medical Innovation...
Showa University School of Medicine

Completed

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study (LANDMARK)

Hemodialysis | Hyperphosphatemia

Japan
Shire

Completed

A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis

Chronic Kidney Disease | Hyperphosphatemia

Germany, Argentina, Chile, Czechia, Hungary, Poland, Romania, Russian Federation, Turkey
SIGA Technologies
PPD; Biomedical Advanced Research and Development Authority

Completed

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Smallpox

United States
Salem Veterans Affairs Medical Center
Shire

Unknown

Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction

Chronic Kidney Disease

United States
Indivior Inc.

Completed

A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder

Alcohol Use Disorder

United States

3

Subscribe